Management of Peripheral Vertigo
Canalith repositioning procedures—specifically the Epley maneuver for posterior canal BPPV—are the definitive first-line treatment for peripheral vertigo, achieving 80% success after 1-3 treatments and 90-98% with repeat maneuvers, while vestibular suppressant medications should be avoided as they provide no benefit for the underlying pathology. 1
Diagnostic Confirmation Before Treatment
- Perform the Dix-Hallpike maneuver bilaterally to diagnose posterior canal BPPV (85-95% of cases), looking for torsional upbeating nystagmus with 5-20 second latency that resolves within 60 seconds 1
- If Dix-Hallpike is negative, conduct the supine roll test to identify horizontal canal BPPV (10-15% of cases), observing for geotropic or apogeotropic nystagmus patterns 1
- No imaging or laboratory testing is required for typical BPPV presentations with positive diagnostic maneuvers and no red-flag features 1, 2
Treatment Algorithm by Canal Type
Posterior Canal BPPV (Most Common)
- Epley maneuver is first-line therapy with the following steps 1:
- Patient seated upright, head turned 45° toward affected ear
- Rapidly lay back to supine with head hanging 20° below horizontal for 20-30 seconds
- Turn head 90° toward unaffected side, hold 20 seconds
- Rotate head and body another 90° to near face-down position, hold 20-30 seconds
- Return to upright sitting position
- Semont (Liberatory) maneuver is an alternative with 94.2% resolution at 6 months, though the Epley shows superior outcomes at 3-month follow-up 1
- Success rates: 80.5% negative Dix-Hallpike by day 7, compared to only 25% with Brandt-Daroff exercises 1
Horizontal Canal BPPV – Geotropic Variant
- Gufoni maneuver (preferred, 93% success rate) 1:
- Move patient from sitting to side-lying on unaffected side for 30 seconds
- Quickly turn head 45-60° toward ground, hold 1-2 minutes
- Return to sitting with head turned toward left shoulder
- Barbecue Roll (Lempert) maneuver (alternative, 50-100% success) involves continuous 360° rotation from supine through prone, holding each position 15-30 seconds 1
Horizontal Canal BPPV – Apogeotropic Variant
- Modified Gufoni maneuver: same steps as standard Gufoni but begin with patient side-lying on the affected side 1
Critical Post-Treatment Instructions
- No postprocedural restrictions are recommended—patients may resume normal activities immediately, including driving, lying flat, and any head positions 1
- Strong evidence demonstrates that head-elevation restrictions, sleep-position limitations, or activity restrictions provide no benefit and may cause unnecessary complications 1
- Reassess within 1 month to confirm symptom resolution or identify persistent BPPV requiring repeat maneuvers 3, 1
Medication Management: What NOT to Do
Vestibular suppressant medications (meclizine, antihistamines, benzodiazepines) should NOT be routinely prescribed for BPPV treatment because 3, 1:
- No evidence supports their effectiveness as definitive treatment for BPPV 3
- They interfere with central compensation mechanisms in peripheral vestibular conditions 3
- They cause significant adverse effects: drowsiness, cognitive deficits, increased fall risk (especially in elderly), and decreased diagnostic sensitivity during Dix-Hallpike testing 1
- They are contraindicated in patients with glaucoma, asthma, or prostate enlargement 4
Limited exception: Vestibular suppressants may be considered only for short-term management (hours to days) of severe nausea/vomiting in severely symptomatic patients refusing repositioning or requiring prophylaxis immediately before/after the procedure 1
Management of Treatment Failures
If symptoms persist after initial repositioning 1:
- Repeat the diagnostic test (Dix-Hallpike or supine roll) to confirm persistent BPPV
- Perform additional repositioning maneuvers—repeat CRPs achieve 90-98% success rates 1
- Check for canal conversion (occurs in 6-7% of cases)—the posterior canal may convert to lateral or vice versa 1
- Evaluate for multiple canal involvement—rare but possible, may require treating different canals 1
- Rule out coexisting vestibular pathology if symptoms occur with general head movements or spontaneously 1
- Consider CNS disorders if atypical features present: downbeating nystagmus, direction-changing nystagmus, focal neurologic deficits, sudden hearing loss, or inability to stand/walk 1, 2
Vestibular Rehabilitation Therapy (VRT)
- Offer VRT as adjunctive therapy (not substitute for repositioning) for patients with 1:
- Residual dizziness after successful CRP
- Postural instability or heightened fall risk
- Persistent symptoms after 2-3 repositioning attempts
- VRT significantly improves gait stability compared to medication alone, particularly beneficial for elderly patients or those with CNS disorders 1
- Brandt-Daroff exercises are less effective than repositioning maneuvers (24% vs 71-74% success at 1 week) but may be appropriate for patients with physical limitations preventing standard maneuvers 1
Self-Treatment Options
- Self-administered Epley maneuver can be taught to motivated patients after at least one properly performed in-office treatment, achieving 64% improvement vs 23% with Brandt-Daroff exercises 1
- Patients should be instructed to return for reassessment if self-treatment is ineffective after 1 week 1
Special Populations Requiring Modified Approach
Assess all patients before treatment for 1:
- Cervical spine pathology: severe cervical stenosis, radiculopathy, rheumatoid arthritis, ankylosing spondylitis—consider modified positioning or Brandt-Daroff exercises instead 1
- Other physical limitations: morbid obesity, Down syndrome, Paget's disease, retinal detachment, spinal cord injuries—may require specialized examination tables or vestibular physical therapy referral 1
- Fall risk factors: impaired mobility/balance, CNS disorders, lack of home support—BPPV increases fall risk 12-fold, especially in elderly (9% prevalence in geriatric patients, 75% had fallen within 3 months) 1
Non-BPPV Peripheral Vertigo
Vestibular Neuritis
- Acute persistent vertigo lasting days to weeks (accounts for 41% of peripheral vertigo cases) 5
- Vestibular suppressants may be used briefly during acute phase only, followed by early vestibular rehabilitation to promote central compensation 5
- Betahistine 48 mg daily for 3 months has demonstrated effectiveness and safety in clinical trials, though not FDA-approved in the United States 6
Ménière's Disease
- Characterized by fluctuating low-to-mid frequency sensorineural hearing loss, aural fullness, tinnitus, and vertigo episodes lasting 20 minutes to 12 hours 1, 5
- Treatment includes salt restriction, diuretics, and intratympanic therapies for refractory cases 1, 5
Vestibular Migraine
- Accounts for 14% of all vertigo cases but is markedly under-recognized 1
- Migraine prophylaxis and lifestyle modifications are recommended, though adequate clinical trial data are limited 1
Common Pitfalls to Avoid
- Do not delay repositioning procedures—any delay between diagnosis and treatment creates a high-risk period for falls and injury 1
- Do not rely on patient descriptions of "spinning" vs "lightheadedness"—focus on timing, triggers, and associated symptoms instead 1, 2
- Do not assume normal neurologic exam excludes stroke—75-80% of posterior circulation stroke patients with acute vestibular syndrome have no focal deficits 2
- Do not order routine imaging for typical BPPV—diagnostic yield is <1% and delays definitive treatment 1, 2
- Do not prescribe vestibular suppressants as primary therapy—they are ineffective for BPPV and delay recovery 3, 1
Red Flags Requiring Urgent Neuroimaging
Obtain MRI brain without contrast immediately for 1, 2:
- Focal neurological deficits (dysarthria, limb weakness, diplopia, Horner's syndrome)
- Sudden unilateral hearing loss
- Inability to stand or walk despite attempts
- Downbeating or purely vertical nystagmus
- Direction-changing nystagmus without head position changes
- New severe headache accompanying vertigo
- Age >50 with vascular risk factors (hypertension, diabetes, atrial fibrillation, prior stroke)
- Abnormal HINTS examination (normal head-impulse test, direction-changing nystagmus, skew deviation)